SEC Form 4 · accession 0001209191-16-129886
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2016 | M | 9,611 | $2.0864 | A | 345,655 | D | |
| Common Stock | Jun 24, 2016 | M | 10,215 | $5.5004 | A | 355,870 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.0864 | Jun 24, 2016 | M | 9,611 | D | — | Jun 4, 2022 | Common Stock | 9,611 | 0 | D |
| Stock option (right to buy)F2 | $5.5004 | Jun 24, 2016 | M | 10,215 | D | — | Jan 16, 2023 | Common Stock | 10,215 | 249,719 | D |
Explanation of responses
- F1This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 1, 2013 and in 36 equal monthly installments thereafter
- F2This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.